This website uses cookies to enhance the user experience.
S

SALT RESEARCH AS929 001 656

Research
Limited company
Havnepromenaden 2 8300 SVOLVÆR, Norge

SALT RESEARCH AS

Keywords

researchdevelopment workbiotechnologygenomicspharmageneticsgene samplesdna sequencingdna synthesisdna deepeninggenetic engineeringproteinsmoleculespeptide sequencinglipidglycotechniqueproteomicshormonesgrowth factorscell receptorspheromonescell culturetissue culturecrossingcell fusionvaccineimmunostimulatorsembryo manipulationprocess biotechnologybioreactorsfermentationbioprocessingbiorecoverybiodesulfurizationbiological pulp productionbiofiltrationbiological regenerationsubcellular organismsgene therapyvirusesvectors

Organization

Chairman of the board
Years since formation
3 years
since Mar 29, 2022
Type
Limited company
VAT registered
Yes
Number of employees
0

Ownership

Number of shares and share classes
30,000
1 share class
Total number of shareholders
1
company
Belongs to group of

Financials

Total operating income 2024
1,241,077
NOK
Annual total result 2024
105,992
NOK
Total equity 2024
125,272
NOK
Last update: Jun 19, 2025

Management

Management / administration

NameRoleShares
Managing Director/CEO
40.33 %
indirectly

Board

NameRoleShares
Chairman
2.33 %
indirectly

Others

NameRoleShares
N
NORDNORSK REVISJON AS
Auditor-
Accountant-

Top 10 individual shareholders

NameRoleShares
Managing Director/CEO
40.33 %
indirectly
Chairman
2.33 %
indirectly
-
2.33 %
indirectly
-
2.33 %
indirectly
-
2.33 %
indirectly
-
1.83 %
indirectly
-
1.83 %
indirectly
-
1.83 %
indirectly
-
1.83 %
indirectly
-
1.83 %
indirectly
Last update: Jan 31, 2024

Ownership

Company shareholders

NameShare classTotal number of sharesShare
S
SALT LOFOTEN AS
Ordinary shares
30,000
100 %
Last update: Jun 2, 2025

Group structure

  • Total operating income 2024: NOK 33,212,140
    Operating profit 2024: NOK 1,583,856
    Employees: 27

Financials

in NOK

Summary

Year202420232022
Total operating income
1,241,077
0
0
Annual Total Result
105,992
-2,729
829
Total assets
2,206,153
19,280
22,634
Total liabilities
2,080,881
0
625
Total equity
125,272
19,280
22,009

P&L

Year202420232022
Total operating income
1,241,077
0
0
Total operating costs
1,105,079
3,499
1,425
Operating result
135,998
-3,499
-1,425
Financial income/costs
-110
0
0
Profit before tax
135,888
-3,499
-1,425
Total tax & extraordinary income/cost
29,896
-770
-2,254
Annual Total Result
105,992
-2,729
829

Balance overview

Year202420232022
Total fixed assets
0
3,024
2,254
Total current assets
2,206,153
16,256
20,380
Total assets
2,206,153
19,280
22,634
Short term debt
2,080,881
0
625
Long term debt
0
0
0
Total liabilities
2,080,881
0
625
Contributed capital
22,009
22,009
22,009
Retained earnings
103,263
-2,729
0
Total equity
125,272
19,280
22,009
Total equity and liabilities
2,206,153
19,280
22,634

Classification

Category
Type of organization
Limited company
Classification of institutional sector
INNL
Domestic sectors
A_IKKE-FIN
Non-financial corporations
2100
Private non-financial incorporated enterprises
Standard industrial classification
M
Main industrial area
Professional, scientific and technical activities
72
Activity
Scientific research and development
72.1
Main industrial group
Research and experimental development on natural sciences and engineering
72.11
Industrial group
Research and experimental development on biotechnology
72.110
Industrial group
Research and experimental development on biotechnology